InvestorsHub Logo
Followers 617
Posts 27445
Boards Moderated 3
Alias Born 11/16/2007

Re: 2014turnaround post# 891

Sunday, 08/28/2016 7:14:59 PM

Sunday, August 28, 2016 7:14:59 PM

Post# of 1137
I'll look to see how that compares to current SOC. In the meantime, do you know why they state the primary endpoints of the trial haven't been met?

I'll check back later for the answer... no hurry since I'm about to be off the computer.

**********

Edit to add.... I see all of your edits to the last post...thanks... I'll read the links later. Creative way to beat post limit. ;)

http://streetregister.com/2016/08/27/nymox-pharmaceutical-corporation-nasdaqnymx-ignore-the-shorts/

I'm out of posts for the day,it blows SOC out of the water,shorts are spinnning the data!

https://prostatecancernewstoday.com/2016/06/23/Fexapotide-reduces-prostate-cancer-bph-men

http://www.empr.com/drugs-in-the-pipeline/fexapotide-vs-conventional-bph-treatments-evaluated-in-crossover-study/article/518832/?webSyncID=a8dacc5e-197e-11a6-5eb8-8d7c8b1c05a5&sessionGUID=be9303b7-5ba3-ba92-0443-ace3cadc1b20







In Reply to '2014turnaround'
Did you read the latest release long term benefit? 85%-92% not requiring surgery?


















To follow KarinCA, click here then click "Follow This Member" under my photo.

Be kinder than necessary, for everyone you meet is fighting some kind of battle.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NYMXF News